IV.2 Does risk of endometrial cancer increase with longer duration of tamoxifen use?

European Journal of Cancer

Volumn 34, Issue SUPPL. 4, 1998, Pages

  Van Leeuwen, F ^a   Bergman, L ^a   Benraadt, J ^a  

^a Integraal Kankercentrum Amsterdam   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

BREAST CANCER; CANCER RISK; CLINICAL TRIAL; CONFERENCE PAPER; ENDOMETRIUM CANCER; HUMAN; PRIORITY JOURNAL; TIME;

EID: 0031710656     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00108-7     Document Type: Conference Paper

References (9)

1. IARC. Some pharmaceutical drugs. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol 66. Lyon, IARC, 1996.
2. Fornander T, Rutqvist LE, Cedermark B, et al. Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers. Lancet 1989, 1, 117-120.
3. Andersson M, Storm HH, Mouridsen HT. Incidence of new primary cancers after adjuvant tamoxifen therapy and radiotherapy for early breast cancer. J Natl Cancer Inst 1991, 83, 1013-1017.
4. Van Leeuwen FE, Benraadt J, Coebergh JWW, et al. Risk of endometrial cancer following breast cancer treatment with tamoxifen. Lancet 1994, 343, 448-452.
5. Fisher B, Costantino JP, Redmond CK, Fisher ER, Wickerham DL, Cronin WM. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst 1994, 86, 527-537.
6. Cook LS, Weiss NS, Schwartz SM, et al. Population-based study of tamoxifen therapy and subsequent ovarian, endometrial and breast cancers. J Natl Cancer Inst 1995, 87, 1359-1364.
7. Rutqvist LE, Johansson H, Signomklao T, Johansson U, Fornander T, Wilking N. Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. J Natl Cancer Inst 1995, 87, 645-651.
8. Curtis RE, Boice JD, Shriner DA, et al. Second cancers after adjuvant therapy for breast cancer. Brief communication. J Natl Cancer Inst 1996, 88, 332-334.
9. Sasco AJ, Chaplain G, Amoros E, Saez S. Endometrial cancer following breast cancer: effect of tamoxifen and castration by radiotherapy. Epidemiology 1996, 7, 9-13.